Biography
Professional Summary
Education & Certifications
- Internship: UCSF Dept of Internal Medicine (1991) CA
- Residency: Stanford University Dermatology Residency (1994) CA
- Medical Education: Perelman School of Medicine University of Pennsylvania (1990) PA
- Board Certification: American Board of Dermatology, Dermatology (1994)
- Chief Residency, Stanford University, Dermatology (1994)
- Dermatology Residency, Stanford University, Dermatology (1994)
- Internship, Univ. of California, San Francisco, Internal Medicine (1991)
- MD, University of Pennsylvania, Medicine (1990)
- BA with Distinction, University of Virginia, Echols Interdisciplinary Studies (Biology/English) (1986)
Honors & Awards
- Certificate of Recognition for medical services rendered through Philos Health NGO, Province of Bohol (Philippines), Municipality of Jagna (2022)
- Elected Member, American Dermatological Association (2011)
- Humanitarian Award Recipient, Melanoma Research Foundation (2012)
- Inaugural Lecturer, Marie-France Demierre Memorial Lectureship, Department of Dermatology, Boston University School of Medicine (2012)
- Keynote Lecturer, Annual Karolinska Dermatology Symposium, Division of Dermatology, Karolinska Institute, Stockholm, Sweden (2013)
- Keynote Lecturer/Visiting Professor, Australian Skin Cancer Melanoma Screening Summit, Dermatology Research Center, University of Queensland, Brisbane, Australia (2019)
- Leadership Award, Melanoma Care Coalition (2007)
- Lecturer, Medicine/Oncology Grand Rounds, Stanley Balcerzak Lectureship, Division of Oncology, Ohio State University Comprehensive Cancer Center (2023)
- Lecturer, Patricia Shellhardt Malone Melanoma Lectureship, Division of Dermatology, Washington University School of Medicine (2018)
- Lecturer/Visiting Professor, David & Margaret Kay Melanoma Lectureship, Department of Dermatology, Johns Hopkins Medicine (2014)
- Lecturer/Visiting Professor, John Zone Endowed Lectureship, Department of Dermatology, University of Utah School of Medicine (2024)
- Lecturer/Visiting Professor, Louis A. Duhring Lectureship, Department of Dermatology, University of Pennsylvania School of Medicine (2022)
- Letter of Teaching Distinction, Department of Dermatology, Stanford Medicine (2020)
- Nominated, Franklin G. Ebaugh, Jr. Award (outstanding dedication to advising medical students), Stanford University School of Medicine (1999, 2001, 2004, 2009)
- Nominated, Kaiser Award for Clinical Teaching, Stanford University School of Medicine (2003, 2004, 2005)
- Plenary Lecturer, German Skin Cancer Congress, German Dermatologic Cooperative Oncology Group (DeCOG) Annual Meeting, Mainz, Germany (2017)
- President's Volunteer Service Award, President's Council on Service & Civic Participation, Corporation for National & Community Service (2007)
- Recognition for Excellence in Teaching, Stanford University School of Medicine (2004, 2009)
- Service Award, 20 Years, Veterans Affairs Palo Alto Health Care System (2014)
- Service Award, 25 years, Veterans Affairs Palo Alto Health Care System (2019)
Administrative Appointments
- Advisory Board, Stanford Women and Sex Differences in Medicine (WSDM) Center (2014 - 2016)
- Chair, AAD Melanoma Work Group, Clinical Practice Guidelines Update, American Academy of Dermatology (2015 - 2019)
- Chair, NCCN Melanoma Panel, National Comprehensive Cancer Network (2020 - Present)
- Co-Director, Pigmented Lesion and Melanoma Program, Stanford Cancer Institute (2023 - Present)
- Co-founder and Co-Chair, Melanoma Prevention Working Group, Cooperative Oncology Intergroup/National Clinical Trials Network (2002 - Present)
- Co-Leader, UV Exposure/Melanoma Advisory Subcommittee, California’s Comprehensive Cancer Control Plan, 2021-2025, California Dialogue on Cancer (CDOC) (2019 - 2021)
- Cutaneous Melanoma Workgroup, International Collaboration on Cancer Reporting (ICCR) Initiative (2018 - 2019)
- Dermatology Council, Melanoma Research Alliance (2019 - Present)
- Director, Pigmented Lesion and Melanoma Program, Stanford Cancer Institute (1995 - 2023)
- Founder and Statewide Leader, Wipe Out Melanoma - California (2018 - Present)
- Founding Member, War on Melanoma™ Federation of States Partnership (2016 - Present)
- Inaugural Member (Affiliate), Stanford Center for Population Health Sciences (2015 - Present)
- International Independent Representative, Strategic Advisory Committee, ACRF/Australian Center for Excellence in Melanoma Imaging & Diagnosis (ACEMID) (2019 - Present)
- Medical Advisory Board, AIM at Melanoma (2005 - Present)
- Medical Advisory Panel, Melanoma Research Alliance (2013 - Present)
- Member, AAD Melanoma Clinical Guidelines Task Force, American Academy of Dermatology (2006 - 2012)
- Member, AAD Melanoma Work Group, Clinical Practice Guidelines Update, American Academy of Dermatology (2023 - Present)
- Member, Board of Directors, American Cancer Society, Santa Clara County Unit (2007 - 2021)
- Member, Council of Cancer Leaders, Stanford Comprehensive Cancer Center (2015 - Present)
- Member, Melanoma/Skin Cancer Committee, American Academy of Dermatology (1999 - 2009)
- Member, NCCN Melanoma Panel, National Comprehensive Cancer Network (2007 - Present)
- Member, Scientific Programs Committee, Melanoma Section, American Society of Clinical Oncology (2006 - 2008)
- Physician Leader, Cancer Care Program in Cutaneous Oncology, Stanford Cancer Institute (2012 - Present)
- President, Board of Directors, American Cancer Society, Santa Clara County Unit (2009 - 2011)
Publications
-
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., … DAVIS, M. M. (1999). Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. NATURE MEDICINE, 5(6), 677–685. -
Hereditary ochronosis: Hyperpigmented skin overlying cartilaginous structures
Garcia, S. F., Egbert, B., & Swetter, S. M. (1999). Hereditary ochronosis: Hyperpigmented skin overlying cartilaginous structures. CUTIS, 63(6), 337–338. -
Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma
Dubois, R. W., Vetter, S. M. S., Atkins, M., McMasters, K., Halbert, R., Miller, S. J., … Kirkwood, J. (2001). Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. ARCHIVES OF DERMATOLOGY, 137(9), 1217–1224. -
Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea
Su, L. D., Kim, Y. H., LeBoit, P. E., Swetter, S. M., & Kohler, S. (2002). Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea. JOURNAL OF CUTANEOUS PATHOLOGY, 29(3), 135–141. -
-
Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California
Swetter, S. M., Waddell, B. L., Vazquez, B. D., & Khosravi, V. S. (2003). Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California. PREVENTIVE MEDICINE, 36(2), 164–171. -
Current management of melanoma: Benefits of surgical staging and adjuvant therapy
McMasters, K. M., & Swetter, S. M. (2003). Current management of melanoma: Benefits of surgical staging and adjuvant therapy. JOURNAL OF SURGICAL ONCOLOGY, 82(3), 209–216. -
-
Dermatological perspectives of malignant melanoma
Swetter, S. M. (2003). Dermatological perspectives of malignant melanoma. SURGICAL CLINICS OF NORTH AMERICA, 83(1), 77-? -
Malignant melanoma
Kanzler, M. H., & Swetter, S. M. (2003). Malignant melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 48(5), 780–783. -
Challenge
STEWART, D. B., Egbert, B. M., & Swetter, S. M. (2003). Challenge. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 25(5), 430-? -
Primary dermal melanoma - A distinct subtype of melanoma
Swetter, S. M., Ecker, P. M., Johnson, D. L., & Harvell, J. D. (2004). Primary dermal melanoma - A distinct subtype of melanoma. ARCHIVES OF DERMATOLOGY, 140(1), 99–103. -
Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis
Chang, H. Y., Cooper, Z. A., Swetter, S. A., & Marinkovich, M. P. (2004). Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis. ARCHIVES OF DERMATOLOGY, 140(2), 242–244. -
Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions
Fiorentino, D. F., Nguyen, J. C., Egbert, B. M., & Swetter, S. M. (2004). Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 50(3), 476–478. -
Diffuse verrucous, vascular nodules on the extremities and trunk
Nguyen, J., Egbert, B. M., & Swetter, S. M. (2004). Diffuse verrucous, vascular nodules on the extremities and trunk. ARCHIVES OF DERMATOLOGY, 140(3), 353-? -
Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome
Harrington, C. R., Egbert, B. M., & Swetter, S. M. (2004). Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. DERMATOLOGIC SURGERY, 30(5), 817–819. -
Melanoma in the older person
Swetter, S. M., Geller, A. C., & Kirkwood, J. M. (2004). Melanoma in the older person. ONCOLOGY-NEW YORK, 18(9), 1187–1196. -
Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction
Farrahi, F., Egbert, B. M., & Swetter, S. M. (2005). Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction. JOURNAL OF CUTANEOUS PATHOLOGY, 32(6), 405–412. -
Sentinel lymph node biopsy for cutaneous melanoma - The Stanford experience, 1997-2004
Berk, D. R., Johnson, D. L., Uzieblo, A., Kiernan, M., & Swetter, S. M. (2005). Sentinel lymph node biopsy for cutaneous melanoma - The Stanford experience, 1997-2004. ARCHIVES OF DERMATOLOGY, 141(8), 1016–1022. -
Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000
Swetter, S. M., Boldrick, J. C., Jung, S. Y., Egbert, B. M., & Harvell, J. D. (2005). Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 125(4), 685–91. -
Sun protection factor content and warning statements for sunless tanning products: An examination of retail outlets and the Internet
Dajani, Z., Swetter, S. M., Demierre, M. F., & Geller, A. C. (2005). Sun protection factor content and warning statements for sunless tanning products: An examination of retail outlets and the Internet. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 53(5), 919–920. -
A call for the development and implementation of a targeted national melanoma screening program
Geller, A. C., Miller, D. R., Swetter, S. M., Demierre, M. F., & Gilchrest, B. A. (2006). A call for the development and implementation of a targeted national melanoma screening program. ARCHIVES OF DERMATOLOGY, 142(4), 504–507. -
Sun care advertising in popular US magazines
Lee, E. T., O'Riordan, D., Swetter, S. M., Demierre, M.-F., Brooks, K., & Geller, A. C. (2006). Sun care advertising in popular US magazines. AMERICAN JOURNAL OF HEALTH PROMOTION, 20(5), 349–352. -
Use of artificial tanning products among young adults
Brooks, K., Brooks, D., Dajani, Z., Swetter, S. M., Powers, E., Pagoto, S., & Geller, A. C. (2006). Use of artificial tanning products among young adults. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 54(6), 1060–1066. -
Facial resurfacing for nonmelanoma skin cancer prophylaxis
Hantash, B. M., Stewart, D. B., Cooper, Z. A., Rehmus, W. E., Koch, R. J., & Swetter, S. M. (2006). Facial resurfacing for nonmelanoma skin cancer prophylaxis. ARCHIVES OF DERMATOLOGY, 142(8), 976–982. -
Evaluation of digital dermoscopy in a pigmented lesion clinic: Clinician versus computer assessment of malignancy risk
Boldrick, J. C., Layton, C. J., Nguyen, J., & Swetter, S. M. (2007). Evaluation of digital dermoscopy in a pigmented lesion clinic: Clinician versus computer assessment of malignancy risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 56(3), 417–21. -
Effect of health care delivery models on melanoma thickness and stage in a university-based referral center - An observational pilot study
Swetter, S. M., Soon, S., Harrington, C. R., & Chen, S. C. (2007). Effect of health care delivery models on melanoma thickness and stage in a university-based referral center - An observational pilot study. ARCHIVES OF DERMATOLOGY, 143(1), 30–36. -
Crafting a melanoma educational campaign to reach middle-aged and older men
Geller, J., Swetter, S. M., Leyson, J., Miller, D. R., Brooks, K., & Geller, A. C. (2006). Crafting a melanoma educational campaign to reach middle-aged and older men. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 10(6), 259–268. -
Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions
Geller, A. C., Swetter, S. M., Brooks, K., Demierre, M.-F., & Yaroch, A. L. (2007). Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 57(4), 555–572. -
Primary dermal melanoma
Cassarino, D. S., Cabral, E. S., Kartha, R. V., & Swetter, S. M. (2008). Primary dermal melanoma. ARCHIVES OF DERMATOLOGY, 144(1), 49–56. -
California medicaid Enrollment and melanoma stage at diagnosis - A population-based study
Pollitt, R. A., Clarke, C. A., Shema, S. J., & Swetter, S. M. (2008). California medicaid Enrollment and melanoma stage at diagnosis - A population-based study. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 35(1), 7–13. -
High-molecular-weight keratin stain as a complement to Melan A stain
Egbert, B. M., Rouse, R. V., & Swetter, S. M. (2008). High-molecular-weight keratin stain as a complement to Melan A stain. JOURNAL OF CUTANEOUS PATHOLOGY, 35(12), 1159–1159. -
-
Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis
Doeden, K., Ma, Z., Narasimhan, B., Swetter, S. M., Detmar, M., & Dadras, S. S. (2009). Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. JOURNAL OF CUTANEOUS PATHOLOGY, 36(7), 772–780. -
-
Factors Related to the Presentation of Thin and Thick Nodular Melanoma From a Population-based Cancer Registry in Queensland Australia
Geller, A. C., Elwood, M., Swetter, S. M., Brooks, D. R., Aitken, J., Youl, P. H., … Baade, P. D. (2009). Factors Related to the Presentation of Thin and Thick Nodular Melanoma From a Population-based Cancer Registry in Queensland Australia. CANCER, 115(6), 1318–1327. -
Melanoma in Middle-aged and Older Men A Multi-institutional Survey Study of Factors Related to Tumor Thickness
Swetter, S. M., Johnson, T. M., Miller, D. R., Layton, C. J., Brooks, K. R., & Geller, A. C. (2009). Melanoma in Middle-aged and Older Men A Multi-institutional Survey Study of Factors Related to Tumor Thickness. ARCHIVES OF DERMATOLOGY, 145(4), 397–404. -
Factors Associated With Physician Discovery of Early Melanoma in Middle-aged and Older Men
Geller, A. C., Johnson, T. M., Miller, D. R., Brooks, K. R., Layton, C. J., & Swetter, S. M. (2009). Factors Associated With Physician Discovery of Early Melanoma in Middle-aged and Older Men. ARCHIVES OF DERMATOLOGY, 145(4), 409–414. -
Gender Differences in Melanoma Awareness and Detection Practices Between Middle-aged and Older Men With Melanoma and Their Female Spouses
Swetter, S. M., Layton, C. J., Johnson, T. M., Brooks, K. R., Miller, D. R., & Geller, A. C. (2009). Gender Differences in Melanoma Awareness and Detection Practices Between Middle-aged and Older Men With Melanoma and Their Female Spouses. ARCHIVES OF DERMATOLOGY, 145(4), 488–490. -
Melanoma
Coit, D. G., Andtbacka, R., Bichakjian, C. K., Dilawari, R. A., Dimaio, D., Guild, V., … Wong, M. K. (2009). Melanoma. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 7(3), 250–275. -
-
-
Efficacy of Skin Self-Examination Practices for Early Melanoma Detection
Pollitt, R. A., Geller, A. C., Brooks, D. R., Johnson, T. M., Park, E. R., & Swetter, S. M. (2009). Efficacy of Skin Self-Examination Practices for Early Melanoma Detection. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(11), 3018–3023. -
Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study
Spanogle, J. P., Clarke, C. A., Aroner, S., & Swetter, S. M. (2010). Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 62(5), 757–767. -
Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults-The Stanford Experience 1995-2008
Berk, D. R., LaBuz, E., Dadras, S. S., Johnson, D. L., & Swetter, S. M. (2010). Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults-The Stanford Experience 1995-2008. PEDIATRIC DERMATOLOGY, 27(3), 244–254. -
-
-
Increases in Melanoma Among Adolescent Girls and Young Women in California Trends by Socioeconomic Status and UV Radiation Exposure
Hausauer, A. K., Swetter, S. M., Cockburn, M. G., & Clarke, C. A. (2011). Increases in Melanoma Among Adolescent Girls and Young Women in California Trends by Socioeconomic Status and UV Radiation Exposure. ARCHIVES OF DERMATOLOGY, 147(7), 783–789. -
Guidelines of care for the management of primary cutaneous melanoma
Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Hood, A. F., Grichnik, J. M., Swetter, S. M., … Begolka, W. S. (2011). Guidelines of care for the management of primary cutaneous melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(5), 1032–1047. -
Reducing mortality in individuals at high risk for advanced melanoma through education and screening
Geller, A. C., Swetter, S. M., Oliveria, S., Dusza, S., & Halpern, A. C. (2011). Reducing mortality in individuals at high risk for advanced melanoma through education and screening. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(5), S87–S94. -
Examining the pathways linking lower socioeconomic status and advanced melanoma
Pollitt, R. A., Swetter, S. M., Johnson, T. M., Patil, P., & Geller, A. C. (2012). Examining the pathways linking lower socioeconomic status and advanced melanoma. CANCER, 118(16), 4004–4013. -
Behavioral determinants of successful early melanoma detection: role of self and physician skin examination.
Swetter, S. M., Pollitt, R. A., Johnson, T. M., Brooks, D. R., & Geller, A. C. (2012). Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer, 118(15), 3725–3734. -
Attitudes Toward Indoor Tanning Among Users of Sunless Tanning Products
Mahoney, A., Swetter, S. M., Biello, K. B., Resnick, E. A., Feuerstein, I., & Geller, A. C. (2012). Attitudes Toward Indoor Tanning Among Users of Sunless Tanning Products. ARCHIVES OF DERMATOLOGY, 148(1), 124–126. -
Survival Is Not the Only Valuable End Point in Melanoma Screening
Curiel-Lewandrowski, C., Kim, C. C., Swetter, S. M., Chen, S. C., Halpern, A. C., Kirkwood, J. M., … Grichnik, J. M. (2012). Survival Is Not the Only Valuable End Point in Melanoma Screening. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 132(5), 1332–1337. -
Melanoma.
Coit, D. G., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., Daud, A., … Urist, M. M. (2012). Melanoma. Journal of the National Comprehensive Cancer Network , 10(3), 366–400. -
Reporting and registering nonmelanoma skin cancers: a compelling public health need
Geller, A. C., & Swetter, S. M. (2012). Reporting and registering nonmelanoma skin cancers: a compelling public health need. BRITISH JOURNAL OF DERMATOLOGY, 166(5), 913–915. -
Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling
Sondak, V. K., Swetter, S. M., & Berwick, M. A. (2012). Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling. JOURNAL OF CLINICAL ONCOLOGY, 30(18), 2177–2178. -
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.
Curiel-Lewandrowski, C., Swetter, S. M., Einspahr, J. G., Hsu, C.-H., Nagle, R., Sagerman, P., … Chow, H.-H. (2012). Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity. Cancer, 118(23), 5848–5856. -
Screening and Prevention Measures for Melanoma: Is There a Survival Advantage?
Curiel-Lewandrowski, C., Chen, S. C., & Swetter, S. M. (2012). Screening and Prevention Measures for Melanoma: Is There a Survival Advantage? CURRENT ONCOLOGY REPORTS, 14(5), 458–67. -
-
-
Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines
Coit, D. G., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., Daud, A., … Ho, M. (2013). Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(4), 395–407. -
Role of aspirin and non-aspirin NSAIDs in preventing melanoma.
Ally, M. S., Swetter, S. M., & Tang, J. Y. (2013). Role of aspirin and non-aspirin NSAIDs in preventing melanoma. Future Oncology , 9(11), 1671–1674. -
SCLEREDEMA REVISITED - A POSTSTREPTOCOCCAL COMPLICATION
Cron, R. Q., & Swetter, S. M. (1994). SCLEREDEMA REVISITED - A POSTSTREPTOCOCCAL COMPLICATION. CLINICAL PEDIATRICS, 33(10), 606–610. -
CUTANEOUS NODULES OF MYCOBACTERIUM-CHELONAE IN AN IMMUNOSUPPRESSED PATIENT WITH PREEXISTING PULMONARY COLONIZATION
Swetter, S. M., Kindel, S. E., & SMOLLER, B. R. (1993). CUTANEOUS NODULES OF MYCOBACTERIUM-CHELONAE IN AN IMMUNOSUPPRESSED PATIENT WITH PREEXISTING PULMONARY COLONIZATION. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 28(2), 352–355. -
Cutaneous myiasis following travel to Belize
Swetter, S. M., Stewart, M. I., & SMOLLER, B. R. (1996). Cutaneous myiasis following travel to Belize. INTERNATIONAL JOURNAL OF DERMATOLOGY, 35(2), 118–120. -
Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California
Wrone, D. A., Swetter, S. M., Egbert, B. M., SMOLLER, B. R., & Khavari, P. A. (1996). Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 35(6), 907–910. -
Surgical margins for malignant melanoma: Another point of view
Kanzler, M. H., & Swetter, S. M. (1996). Surgical margins for malignant melanoma: Another point of view. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 35(6), 1014–1015. -
Malignant melanoma from the dermatologic perspective
Swetter, S. M. (1996). Malignant melanoma from the dermatologic perspective. SURGICAL CLINICS OF NORTH AMERICA, 76(6), 1287-? -
Dopamine-associated symmetric peripheral gangrene
Park, J. Y., KANZLER, M., & Swetter, S. M. (1997). Dopamine-associated symmetric peripheral gangrene. ARCHIVES OF DERMATOLOGY, 133(2), 247–249. -
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus
Swetter, S. M., HILL, E. L., Kern, E. R., Koelle, D. M., Posavad, C. M., LAWRENCE, W., & Safrin, S. (1998). Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. JOURNAL OF INFECTIOUS DISEASES, 177(3), 543–550. -
Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma
Swetter, S. M., Yaghmai, D., & Egbert, B. M. (1998). Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma. JOURNAL OF CUTANEOUS PATHOLOGY, 25(8), 420–425. -
The rationale behind the 2002 AJCC Melanoma Staging Committee recommendations
The rationale behind the 2002 AJCC Melanoma Staging Committee recommendations. (2001). The Melanoma Letter, 19(4). -
Vaccine therapy of melanoma: an update.
Vaccine therapy of melanoma: an update. (2005). Current Cancer Therapy Reviews, 1. -
Prevention and detection of melanoma in the primary care setting.
Prevention and detection of melanoma in the primary care setting. (2005). J Clin Outcomes Management, 12. -
Malignant Melanoma
Malignant Melanoma. (2005). EMedicine Journal [Serial Online]. Available at: Http://Www.emedicine.com/Derm/topic257.Htm. -
Slow-growing nodule on the thigh - Solitary fibrous tumor (SFT)
Stewart, D. B., Egbert, B. M., Rouse, R. V., & Swetter, S. M. (2006). Slow-growing nodule on the thigh - Solitary fibrous tumor (SFT). ARCHIVES OF DERMATOLOGY, 142(7), 923-? -
Selection criteria for genetic assessment of patients with familial melanoma
Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., … Tsao, H. (2009). Selection criteria for genetic assessment of patients with familial melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 61(4), 677–84. -
Effect of oral sulindac on biomarkers of drug bioavailability and carcinogenesis in melanocytic nevi-A double-blind, randomized, placebo-controlled trial
Curiel-Lewandrowski, C., Swetter, S., Einspahr, J., Hsu, C., Saboda, K., Nagle, R., … Chow, H. (2011). Effect of oral sulindac on biomarkers of drug bioavailability and carcinogenesis in melanocytic nevi-A double-blind, randomized, placebo-controlled trial. Presented at the 71st Annual Meeting of the Society-for-Investigative-Dermatology, PHOENIX,AZ: NATURE PUBLISHING GROUP. -
-
Dermatomyositis associated with capecitabine in the setting of malignancy.
Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. Journal of the American Academy of Dermatology, 70(2), e47–8. -
Melanoma, version 4.2014.
Coit, D. G., Thompson, J. A., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., … Ho, M. (2014). Melanoma, version 4.2014. Journal of the National Comprehensive Cancer Network , 12(5), 621–629. -
-
-
Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative.
Wysong, A., Ally, M. S., Gamba, C. S., Desai, M., Swetter, S. M., Seiffert-Sinha, K., … Tang, J. Y. (2014). Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative. Preventive Medicine, 69, 8–12. -
Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy.
Chen, F. W., Tseng, D., Reddy, S., Daud, A. I., & Swetter, S. M. (2014). Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy. JAMA Dermatology, 150(11), 1209–1212. -
Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma.
Cloyd, J. M., Wapnir, I. L., Read, B. M., Swetter, S., & Greco, R. S. (2014). Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma. Journal of Surgical Oncology, 110(7), 888–92. -
Measuring the severity of topical 5-Fluorouracil toxicity.
Korgavkar, K., Firoz, E. F., Xiong, M., Lew, R., Marcolivio, K., Burnside, N., … Weinstock, M. A. (2014). Measuring the severity of topical 5-Fluorouracil toxicity. Journal of Cutaneous Medicine and Surgery, 18(4), 229–235. -
-
The Impact of Indoor Tanning Legislation: Newspaper Coverage of the Risks of Indoor Tanning Before and After the California Indoor Tanning Ban for Minors
Mayer, J. E., Swetter, S. M., Guild, S., & Geller, A. C. (2015). The Impact of Indoor Tanning Legislation: Newspaper Coverage of the Risks of Indoor Tanning Before and After the California Indoor Tanning Ban for Minors. JOURNAL OF CANCER EDUCATION, 30(1), 124–129. -
-
Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population
Talaganis, J. A., Biello, K., Plaka, M., Polydorou, D., Papadopoulos, O., Trakatelli, M., … Stratigos, A. J. (2014). Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population. BRITISH JOURNAL OF DERMATOLOGY, 171(4), 832–838. -
Reliability of quantification measures of actinic keratosis
Chen, S. C., Hill, N. D., Veledar, E., Swetter, S. M., & Weinstock, M. A. (2013). Reliability of quantification measures of actinic keratosis. BRITISH JOURNAL OF DERMATOLOGY, 169(6), 1219–1222. -
Acquired blue nevi in older individuals: retrospective case series from a Veterans Affairs population, 1991 to 2013.
Cabral, E. S., Chen, F. W., Egbert, B. M., & Swetter, S. M. (2014). Acquired blue nevi in older individuals: retrospective case series from a Veterans Affairs population, 1991 to 2013. JAMA Dermatology, 150(8), 873–876. -
Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part II. Screening, education, and future directions.
Mayer, J. E., Swetter, S. M., Fu, T., & Geller, A. C. (2014). Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part II. Screening, education, and future directions. Journal of the American Academy of Dermatology, 71(4), 611 e1–611 e10. -
Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology.
Mayer, J. E., Swetter, S. M., Fu, T., & Geller, A. C. (2014). Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology. Journal of the American Academy of Dermatology, 71(4), 599 e1–599 e12. -
-
-
Health behaviors and needs of melanoma survivors
Palesh, O., Aldridge-Gerry, A., Bugos, K., Pickham, D., Chen, J. J., Greco, R., & Swetter, S. M. (2014). Health behaviors and needs of melanoma survivors. SUPPORTIVE CARE IN CANCER, 22(11), 2973–80. -
Dermatomyositis associated with capecitabine in the setting of malignancy
Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(2), E47–E48. -
Indocyanine Green and Fluorescence Lymphangiography for Sentinel Lymph Node Identification in Cutaneous Melanoma
Cloyd, J. M., Wapnir, I. L., Read, B. M., Swetter, S., & Greco, R. S. (2014). Indocyanine Green and Fluorescence Lymphangiography for Sentinel Lymph Node Identification in Cutaneous Melanoma. JOURNAL OF SURGICAL ONCOLOGY, 110(7), 888–92. -
-
-
-
Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men
Kaveh, A. H., Seminara, N. M., Barnes, M. A., Berger, A. J., Chen, F. W., Yao, M., … Sunwoo, J. B. (2016). Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38, E754–E760. -
Addressing the Knowledge Gap in Clinical Recommendations for Management and Complete Excision of Clinically Atypical Nevi/Dysplastic Nevi Pigmented Lesion Subcommittee Consensus Statement
Kim, C. C., Swetter, S. M., Curiel-Lewandrowski, C., Grichnik, J. M., Grossman, D., Halpern, A. C., … Chen, S. C. (2015). Addressing the Knowledge Gap in Clinical Recommendations for Management and Complete Excision of Clinically Atypical Nevi/Dysplastic Nevi Pigmented Lesion Subcommittee Consensus Statement. JAMA DERMATOLOGY, 151(2), 212–218. -
Perspective: catch melanoma early.
Swetter, S. M., & Geller, A. C. (2014). Perspective: catch melanoma early. Nature, 515(7527), S117-? -
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type
Swetter, S. M., Chen, F. W., Kim, D. D., & Egbert, B. M. (2015). Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(6), 1047–1053. -
Tumor Ulceration Does Not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults.
Keegan, T. H. M., Swetter, S. M., Tao, L., Sunwoo, J. B., & Clarke, C. A. (2015). Tumor Ulceration Does Not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults. Journal of Investigative Dermatology, 135(12), 3195–3197. -
-
Focus on early detection to reduce melanoma deaths.
Geller, A. C., Swetter, S. M., & Weinstock, M. A. (2015). Focus on early detection to reduce melanoma deaths. Journal of Investigative Dermatology, 135(4), 947–949. -
Tumor volume: an adjunct prognostic factor in cutaneous melanoma.
Walton, R. G., Kim, J., Velasco, C., & Swetter, S. M. (2014). Tumor volume: an adjunct prognostic factor in cutaneous melanoma. Cutis, 94(5), 226–230. -
-
Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
Geller, A. C., Mayer, J. E., Sober, A. J., Miller, D. R., Argenziano, G., Johnson, T. M., & Swetter, S. M. (2016). Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers. JAMA Dermatology, 152(4), 413–418. -
-
-
Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi
Fleming, N. H., Egbert, B. M., Kim, J., & Swetter, S. M. (2016). Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi. JAMA DERMATOLOGY, 152(12), 1327–34. -
-
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Carson, W. E., … Engh, A. (2016). Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network , 14(4), 450–473. -
NCCN Guidelines Insights: Melanoma, Version 3.2016.
Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Carson, W. E., … Engh, A. (2016). NCCN Guidelines Insights: Melanoma, Version 3.2016. Journal of the National Comprehensive Cancer Network , 14(8), 945–958. -
-
What the USPSTF "Insufficient" Skin Cancer Screening Recommendation Means for Primary Care Clinicians and Dermatologists.
Swetter, S. M., Geller, A. C., & Halpern, A. C. (2016). What the USPSTF "Insufficient" Skin Cancer Screening Recommendation Means for Primary Care Clinicians and Dermatologists. JAMA Dermatology, 152(9), 973–975. -
Association of nevus count with prevention attitudes and behaviors before melanoma diagnosis.
Mayer, J. E., Swetter, S. M., Miller, D. R., Sober, A. J., Johnson, T. M., & Geller, A. C. (2016). Association of nevus count with prevention attitudes and behaviors before melanoma diagnosis. Melanoma Research, 26(5), 513–516. -
Enhanced radiation dermatitis associated with concurrent palliative radiation and vemurafenib therapy.
Kuo, K. Y., Jiang, W., & Swetter, S. M. (2016). Enhanced radiation dermatitis associated with concurrent palliative radiation and vemurafenib therapy. Cutis, 97(2), E4–6. -
Cutaneous Complications of Targeted Melanoma Therapy.
de Golian, E., Kwong, B. Y., Swetter, S. M., & Pugliese, S. B. (2016). Cutaneous Complications of Targeted Melanoma Therapy. Current Treatment Options in Oncology, 17(11), 57-? -
Methods of Melanoma Detection.
Leachman, S. A., Cassidy, P. B., Chen, S. C., Curiel, C., Geller, A., Gareau, D., … Weinstock, M. A. (2016). Methods of Melanoma Detection. Cancer Treatment and Research, 167, 51–105. -
-
-
-
Melanoma
Colt, D. G., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., Daud, A., … Urist, M. M. (2012). Melanoma. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(3), 366–400. -
Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma.
Jaju, P., Novoa, R. A., Swetter, S. M., & Sarin, K. Y. (2016). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. Pediatric Dermatology. -
-
-
Lack of harms from community-based melanoma screening by primary care providers.
Curiel-Lewandrowski, C., & Swetter, S. M. (2016). Lack of harms from community-based melanoma screening by primary care providers. Cancer, 122(20), 3102–3105. -
Dermatologist-level classification of skin cancer with deep neural networks.
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–18. -
-
-
Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.
Swetter, S. M., Chang, J., Shaub, A. R., Weinstock, M. A., Lewis, E. T., & Asch, S. M. (2017). Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System. JAMA Dermatology. -
Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682. -
-
Aspirin is associated with lower melanoma risk in a cohort of postmenopausal women in the Women's Health Initiative (WHI)
Swetter, S. M., Gamba, C. A., Stefanick, M. L., Spaunhurst, K. M., Kubo, J., Desai, M., … Tang, J. Y. (2012). Aspirin is associated with lower melanoma risk in a cohort of postmenopausal women in the Women's Health Initiative (WHI). JOURNAL OF INVESTIGATIVE DERMATOLOGY. NATURE PUBLISHING GROUP. -
Health behaviors and survivorship needs of short-versus long-term melanoma survivors
Swetter, S. M., Gerry, A. A., Bugos, K., Greco, R. S., McGurk, K. L., & Palesh, O. (2013). Health behaviors and survivorship needs of short-versus long-term melanoma survivors. JOURNAL OF CLINICAL ONCOLOGY, 31(15). -
-
Patient Perceptions of Primary Care-Based Skin Cancer Screening
Shaub, A. R., Lewis, E. T., & Swetter, S. M. (2017). Patient Perceptions of Primary Care-Based Skin Cancer Screening. JAMA DERMATOLOGY, 153(11), 1192–93. -
-
-
-
-
Phase I Trial: SABR and Ipilimumab-Letter.
Hiniker, S. M., Reddy, S. A., Swetter, S. M., & Knox, S. J. (2017). Phase I Trial: SABR and Ipilimumab-Letter. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 23(1), 320. -
Management strategies of academic pigmented lesion clinic directors in the United States
Nelson, K. C., Grossman, D., Kim, C. C., Chen, S. C., Curiel-Lewandrowski, C. N., Grichnik, J. M., … Ming, M. E. (2018). Management strategies of academic pigmented lesion clinic directors in the United States. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 79(2), 367–69. -
-
-
-
-
Guidelines of care for the management of primary cutaneous melanoma.
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., … Lamina, T. (2018). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. -
Cross-contamination of Pathology Specimens: A Cautionary Tale
Lewellis, S. W., Roy, K., Gojenola, L., Swetter, S. M., & Rieger, K. E. (2018). Cross-contamination of Pathology Specimens: A Cautionary Tale. CUTIS, 102(4), E12–E14. -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Challenge. Epithelioid cell histiocytoma.
Stewart, D. B., Egbert, B. M., & Swetter, S. M. (2003). Challenge. Epithelioid cell histiocytoma. The American Journal of Dermatopathology, 25(5), 430–1, 445. -
Improving care with portfolio of physician-led cancer quality measures at an academic center
Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Artificial intelligence and dermatology: opportunities, challenges, and future directions.
Schlessinger, D. I., Chhor, G., Gevaert, O., Swetter, S. M., Ko, J., & Novoa, R. A. (2019). Artificial intelligence and dermatology: opportunities, challenges, and future directions. Seminars in Cutaneous Medicine and Surgery, 38(1), E31–37. -
-
Outcomes of surgical re-excision versus observation of severely dysplastic nevi: a single institution, retrospective cohort study.
Fleming, N. H., Shaub, A. R., Bailey, E., & Swetter, S. M. (2019). Outcomes of surgical re-excision versus observation of severely dysplastic nevi: a single institution, retrospective cohort study. Journal of the American Academy of Dermatology. -
-
Use of new molecular tests for melanoma by pigmented lesion experts.
Varedi, A., Gardner, L. J., Kim, C. C., Chu, E. Y., Ming, M. E., Leachman, S. A., … Grossman, D. (2019). Use of new molecular tests for melanoma by pigmented lesion experts. Journal of the American Academy of Dermatology. -
Physician perceptions of primary-care-based skin cancer screening in a Veterans Affairs pilot study
Shaub, A. R., Lewis, E. T., Nevedal, A. L., & Swetter, S. M. (2019). Physician perceptions of primary-care-based skin cancer screening in a Veterans Affairs pilot study. BRITISH JOURNAL OF DERMATOLOGY, 181(2), 377–78. -
-
-
-
Consensus Recommendations for the Use of Non-Invasive Melanoma Detection Techniques Based on Results of an International DELPHI Process.
Waldman, R. A., Grant-Kels, J. M., Curiel, C. N., Curtis, J., Rodríguez, S. G., Hu, S., … Swetter, S. M. (2019). Consensus Recommendations for the Use of Non-Invasive Melanoma Detection Techniques Based on Results of an International DELPHI Process. Journal of the American Academy of Dermatology. -
Association of Number of Indoor Tanning Salons With Neighborhoods With Higher Concentrations of Male-Male Partnered Households.
Chen, R., Hipp, J. A., Morrison, L., Henriksen, L., Swetter, S. M., & Linos, E. (2019). Association of Number of Indoor Tanning Salons With Neighborhoods With Higher Concentrations of Male-Male Partnered Households. JAMA Network Open, 2(10), e1912443. -
-
-
Artificial intelligence and dermatology: opportunities, challenges, and future directions
Schlessinger, D. I., Chhor, G., Gevaert, O., Swetter, S. M., Ko, J., & Novoa, R. A. (2019). Artificial intelligence and dermatology: opportunities, challenges, and future directions. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 38(1), E31–E37. -
Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice.
Grossman, D., Kim, C. C., Hartman, R. I., Berry, E., Nelson, K. C., Okwundu, N., … Swetter, S. M. (2019). Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice. Melanoma Management, 6(4), MMT32. -
Adequacy of conservative 2-3 mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: retrospective case series at a tertiary academic institution.
Soleymani, T., Swetter, S. M., Hollmig, S. T., & Aasi, S. Z. (2020). Adequacy of conservative 2-3 mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: retrospective case series at a tertiary academic institution. Journal of the American Academy of Dermatology. -
Uveal Melanoma, Version 1.2019 Featured Updates to the NCCN Guidelines
Rao, P. K., Barker, C., Coit, D. G., Joseph, R. W., Materin, M., Rengan, R., … Engh, A. (2020). Uveal Melanoma, Version 1.2019 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 18(2), 121–31. -
Local recurrence of clinically observed basal cell carcinomas following complete saucerization or punch removal with negative margins: retrospective case series from 2010 to 2020.
Ransohoff, K. J., Nord, K. M., Bailey, E. E., Ransohoff, J. D., Li, S., & Swetter, S. M. (2020). Local recurrence of clinically observed basal cell carcinomas following complete saucerization or punch removal with negative margins: retrospective case series from 2010 to 2020. Journal of the American Academy of Dermatology. -
Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab.
Sodji, Q. H., Gutkin, P. M., Swetter, S. M., Reddy, S. A., Hiniker, S. M., & Knox, S. J. (2020). Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab. Melanoma Management, 7(1), MMT36. -
The estimated financial impact of diagnostic accuracy on melanoma diagnosis in 2018
Nelson, K., Swetter, S. M., Chen, S., & Curiel-Lewandrowski, C. (2018). The estimated financial impact of diagnostic accuracy on melanoma diagnosis in 2018. JOURNAL OF CLINICAL ONCOLOGY, 36(15). -
Virtual melanoma checks during a pandemic.
Janda, M., Swetter, S. M., Horsham, C., & Soyer, H. P. (2020). Virtual melanoma checks during a pandemic. The British Journal of Dermatology. -
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
Grossman, D., Okwundu, N., Bartlett, E. K., Marchetti, M. A., Othus, M., Coit, D. G., … Swetter, S. M. (2020). Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatology. -
Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts.
Fried, L. J., Tan, A., Berry, E. G., Braun, R. P., Curiel-Lewandrowski, C., Curtis, J., … Liebman, T. N. (2021). Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts. JAMA Dermatology. -
The State of Melanoma: Emergent Challenges and Opportunities.
Atkins, M. B., Curiel-Lewandrowski, C., Fisher, D. E., Swetter, S. M., Tsao, H., Aguirre-Ghiso, J. A., … Merlino, G. (2021). The State of Melanoma: Emergent Challenges and Opportunities. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. -
Melanoma toolkit for early detection (MTED) for primary care providers: A pilot study.
Orfaly, V. E., Berry, E. G., Stoos, E. R., Latour, E., Becevic, M., Black, S. M., … Leachman, S. A. (2021). Melanoma toolkit for early detection (MTED) for primary care providers: A pilot study. Pigment Cell & Melanoma Research. -
Patient-identified early clinical warning signs of nodular melanoma: a qualitative study.
Coroiu, A., Moran, C., Davine, J. A., Brophy, K., Bergeron, C., Tsao, H., … Geller, A. C. (2021). Patient-identified early clinical warning signs of nodular melanoma: a qualitative study. BMC Cancer, 21(1), 371. -
Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up
Chambers, M., Swetter, S. M., Baker, C., Saunders, E., & Chapman, M. S. (2021). Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up. JOURNAL OF DRUGS IN DERMATOLOGY, 20(3), 346–48. -
Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer screening program - A cross-sectional analysis.
Beaulieu, D., Gao, D. X., Swetter, S. M., Hawryluk, E. B., & Geller, A. C. (2021). Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer screening program - A cross-sectional analysis. Journal of the American Academy of Dermatology. -
Melanoma: Cutaneous, Version 2.2021 Featured Updates to the NCCN Guidelines
Swetter, S. M., Thompson, J. A., Albertini, M. R., Barker, C. A., Baumgartner, J., Boland, G., … Engh, A. M. (2021). Melanoma: Cutaneous, Version 2.2021 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 19(4), 365-+. -
Cutaneous Melanoma: Management of Melanoma Brain Metastases and Molecular Testing
Johnson, D. B., Swetter, S. M., Salama, A. K. S., & Wuthrick, E. (2021). Cutaneous Melanoma: Management of Melanoma Brain Metastases and Molecular Testing. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 19(5.5), 644–647. -
Efficacy of regional nodal ultrasound surveillance for metastatic detection in sentinel- and complete lymph node dissection-eligible melanoma patients.
Swetter, S. M., Liu, L. Y., Gyurdzhyan, S., & Zaba, L. C. (2021). Efficacy of regional nodal ultrasound surveillance for metastatic detection in sentinel- and complete lymph node dissection-eligible melanoma patients. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Differences in Thickness-Specific Incidence and Factors Associated With Cutaneous Melanoma in the US From 2010 to 2018.
Chen, M. L., de Vere Hunt, I. J., John, E. M., Weinstock, M. A., Swetter, S. M., & Linos, E. (2022). Differences in Thickness-Specific Incidence and Factors Associated With Cutaneous Melanoma in the US From 2010 to 2018. JAMA Oncology. -
Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts.
Bartlett, E. K., Grossman, D., Swetter, S. M., Leachman, S. A., Curiel-Lewandrowski, C., Dusza, S. W., … Marchetti, M. A. (2022). Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts. Annals of Surgical Oncology. -
ASO Visual Abstract:Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts.
Bartlett, E. K., Grossman, D., Swetter, S. M., Leachman, S. A., Curiel-Lewandrowski, C., Dusza, S. W., … Marchetti, M. A. (2022). ASO Visual Abstract:Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts. Annals of Surgical Oncology. -
Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study.
Trepanowski, N., Chang, M. S., Zhou, G., Ahmad, M., Berry, E. G., Bui, K., … Hartman, R. I. (2022). Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study. Journal of the American Academy of Dermatology. -
Screening motivations among participants of the American Academy of Dermatology's SPOT Skin Cancer® screening program from 2018 to 2019: A cross-sectional analysis.
Gao, D. X., Swetter, S. M., Hawryluk, E. B., Geller, A. C., & Beaulieu, D. (2022). Screening motivations among participants of the American Academy of Dermatology's SPOT Skin Cancer® screening program from 2018 to 2019: A cross-sectional analysis. Journal of the American Academy of Dermatology. -
Disparities in dermatology AI performance on a diverse, curated clinical image set.
Daneshjou, R., Vodrahalli, K., Novoa, R. A., Jenkins, M., Liang, W., Rotemberg, V., … Chiou, A. S. (2022). Disparities in dermatology AI performance on a diverse, curated clinical image set. Science Advances, 8(32), eabq6147. -
Differences in tumor thickness-specific incidence of cutaneous melanoma
Chen, M., Hunt, I. de V., John, E., Weinstock, M., Swetter, S., & Linos, E. (2022). Differences in tumor thickness-specific incidence of cutaneous melanoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
A qualitative exploration of melanoma awareness in black communities
Hunt, I. de V., Owen, S., Amuzie, A., Nava, V., Tomz, A., Barnes, L. A., … Linos, E. (2022). A qualitative exploration of melanoma awareness in black communities. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Associations between dietary and supplemental vitamin A and skin cancer risk in postmenopausal women
So, J., Li, S., Linos, E., Swetter, S., Stefanick, M. L., & Tang, J. (2022). Associations between dietary and supplemental vitamin A and skin cancer risk in postmenopausal women. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Lack of association between dietary and supplemental vitamin E intake with skin cancer risk in postmenopausal women
So, J., Li, S., Linos, E., Swetter, S., Stefanick, M. L., & Tang, J. (2022). Lack of association between dietary and supplemental vitamin E intake with skin cancer risk in postmenopausal women. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020.
Qian, M. F., Betancourt, N. J., Pineda, A., Maloney, N. J., Nguyen, K. A., Reddy, S. A., … Zaba, L. C. (2022). Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020. The Oncologist. -
A qualitative exploration of melanoma awareness and prevention among Latinx and non-Latinx White populations in urban and rural California.
Swetter, S. M., Mesia, R. J., Espinosa, P. R., Hutchison, H., Safaeinili, N., Finster, L. J., … Rosas, L. G. (2022). A qualitative exploration of melanoma awareness and prevention among Latinx and non-Latinx White populations in urban and rural California. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Melanoma awareness and prevention among latinx and non-latinx white adults in urban and rural California: A qualitative exploration.
Mesia, R. J., Espinosa, P. R., Hutchison, H., Safaeinili, N., Finster, L. J., Muralidharan, V., … Swetter, S. M. (2022). Melanoma awareness and prevention among latinx and non-latinx white adults in urban and rural California: A qualitative exploration. Cancer Medicine. -
Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma.
Huerta, T., Swetter, S. M., Nehal, K. S., Coit, D. G., Bichakjian, C. K., & Durham, A. B. (2022). Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma. Journal of the American Academy of Dermatology. -
ReUnidos: Farmworker Skin Cancer Health Navigation Program
Savage, D. J., Tushla, L. A., Guenin, K., Gross, I., Kanakarajaveu, N., Young, R., … Arcury, T. (2022). ReUnidos: Farmworker Skin Cancer Health Navigation Program. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Qualitative exploration of melanoma awareness in black people in the USA.
de Vere Hunt, I., Owen, S., Amuzie, A., Nava, V., Tomz, A., Barnes, L., … Linos, E. (2023). Qualitative exploration of melanoma awareness in black people in the USA. BMJ Open, 13(1), e066967. -
Analysis of utilization of skin cancer screenings and screening motivations among national SPOT Skin Cancer program screenees from 2018 to 2019
Gao, D. X., Swetter, S. M., & Hawryluk, E. B. (2022). Analysis of utilization of skin cancer screenings and screening motivations among national SPOT Skin Cancer program screenees from 2018 to 2019. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
What Is Melanoma?
Wang, J. Y., Wang, E. B., & Swetter, S. M. (2023). What Is Melanoma? JAMA. -
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
Kashani-Sabet, M., Leachman, S. A., Stein, J. A., Arbiser, J. L., Berry, E. G., Celebi, J. T., … Kirkwood, J. M. (2023). Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing. JAMA Dermatology. -
Clinical outcomes of squamous cell carcinomas following complete saucerization with negative margins: Retrospective case series from 2010-2022.
Dizon, M. P., Nord, K. M., & Swetter, S. M. (2023). Clinical outcomes of squamous cell carcinomas following complete saucerization with negative margins: Retrospective case series from 2010-2022. JAAD International, 11, 83–84. -
Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014
Cai, E. D., Swetter, S. M., & Sarin, K. Y. (2023). Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 88(5), e211–e219. -
Advances in cutaneous squamous cell carcinoma.
Winge, M. C., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., … Khavari, P. A. (2023). Advances in cutaneous squamous cell carcinoma. Nature Reviews. Cancer. -
Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna.
Longo, C., Navarrete-Dechent, C., Tschandl, P., Apalla, Z., Argenziano, G., Braun, R. P., … Lallas, A. (2023). Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna. Dermatology Practical & Conceptual, 13(3). -
Cutaneous melanoma.
Long, G. V., Swetter, S. M., Menzies, A. M., Gershenwald, J. E., & Scolyer, R. A. (2023). Cutaneous melanoma. Lancet (London, England). -
Single institution validation of a sentinel lymph node biopsy risk prediction tool for cutaneous melanoma
Muralidharan, V., Maddineni, S., Young, L., Sunwoo, J., Baik, F. M., & Swetter, S. (2023). Single institution validation of a sentinel lymph node biopsy risk prediction tool for cutaneous melanoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Estimating Remaining Life Expectancy in Veterans with Basal Cell Carcinoma Using an Automated Electronic Health Record Scoring System: A Retrospective Cohort Study.
Dizon, M. P., Linos, E., & Swetter, S. M. (2023). Estimating Remaining Life Expectancy in Veterans with Basal Cell Carcinoma Using an Automated Electronic Health Record Scoring System: A Retrospective Cohort Study. Journal of the American Academy of Dermatology. -
Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients.
Kim, D. Y., Swetter, S. M., Huhmann, L., Dizon, M. P., Ferguson, J. M., Osborne, T. F., … Hartman, R. I. (2023). Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients. Journal of the American Academy of Dermatology. -
Analysis of utilization of sun-protective behavior among national SPOT Skin Cancer® program screenees from 2018 to 2019
Gao, D., Swetter, S., Hawryluk, E., Geller, A., & Beaulieu, D. (2023). Analysis of utilization of sun-protective behavior among national SPOT Skin Cancer® program screenees from 2018 to 2019. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
The Impact of the COVID-19 Pandemic on Sun Habits of Patients with Melanoma: A Cross- sectional Study
Trepanowski, N., Hathaway, C. A., Chang, M. S., Hay, J. L., Samatham, R., Swetter, S. M., … Hartman, R. I. (2023). The Impact of the COVID-19 Pandemic on Sun Habits of Patients with Melanoma: A Cross- sectional Study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER. -
Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni, S., Dizon, M. P., Muralidharan, V., Young, L. A., Sunwoo, J. B., Baik, F. M., & Swetter, S. M. (2024). Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma. Annals of Surgical Oncology. -
ASO Visual Abstract: Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni, S., Dizon, M. P., Muralidharan, V., Young, L. A., Sunwoo, J. B., Baik, F. M., & Swetter, S. M. (2024). ASO Visual Abstract: Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma. Annals of Surgical Oncology. -
Nodal ultrasound for regional recurrence detection in sentinel lymph node biopsy-positive cutaneous melanoma patients undergoing cross-sectional imaging.
Gyurdzhyan, S., Muralidharan, V., Liu, L. Y., Sunwoo, J. B., Zaba, L. C., & Swetter, S. M. (2024). Nodal ultrasound for regional recurrence detection in sentinel lymph node biopsy-positive cutaneous melanoma patients undergoing cross-sectional imaging. Skin Health and Disease, 4(1), e305. -
Toward the Development of Functional Biomarker Assays: Analysis of Neoadjuvant Intralesional Oncolytic Virus Response in High-Risk Stage II Melanoma
Kirane, A., Lee, D., Ahmad, M. U., Sharma, S., Serasanambati, M., Lowe, M., … Maverakis, E. (2024). Toward the Development of Functional Biomarker Assays: Analysis of Neoadjuvant Intralesional Oncolytic Virus Response in High-Risk Stage II Melanoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma »
- Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma »
- A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma »
- Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy »
- A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma »
- Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing »
- Compassionate Use Trial for Unresectable Melanoma With Ipilimumab »
- Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma »
Practice Locations
Cancer Immunotherapy Program Palo Alto, CA
Palo Alto, CACancer Immunotherapy Program
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Skin Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CASkin Cancer Program in Palo Alto
900 Blake Wilbur Drive, 3rd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Pigmented Lesion and Melanoma Clinic at Stanford Medicine Outpatient Center Redwood City, CA
Redwood City, CAPigmented Lesion and Melanoma Clinic at Stanford Medicine Outpatient Center
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information » Getting Here »Patient Reviews
(99 reviews)
View More »
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology orders
- View referral status
- Access medical records